NRAS and cancer: Based on molecular inversion probe technology, the assay currently detects 74 somatic mutations commonly found in 9 cancer genes (BRAF, KRAS, EGFR, IDH1, IDH2, PTEN, PIK3CA, NRAS and TP53).